Nine-year effects of 3.7 years of intensive glycemic control on cardiovascular outcomes

Hertzel C. Gerstein, Daniel P. Beavers, Alain G. Bertoni, J. Thomas Bigger, John B. Buse, Timothy E. Craven, William C. Cushman, Vivian Fonseca, Nancy L. Geller, Stephen J. Giddings, Richard H. Grimm, Saul Genuth, Irene Hramiak, Faramarz Ismail-Beigi, Carlos R Lopez Jimenez, Ruth Kirby, Jeffrey Probstfield, Matthew C. Riddle, Elizabeth R. Seaquist, William T. Friedewald

Research output: Contribution to journalArticlepeer-review

146 Scopus citations


OBJECTIVE: In the Action to Control Cardiovascular Risk in Diabetes (ACCORD) trial, ∼4 years of intensive versus standard glycemic control in participants with type 2 diabetes and other cardiovascular risk factors had a neutral effect on the composite cardiovascular outcome, increased cardiovascular and total mortality, and reduced nonfatal myocardial infarction. Effects of the intervention during prolonged follow-up were analyzed. RESEARCH DESIGN AND METHODS: All surviving ACCORD participants were invited to participate in the ACCORD Follow-on (ACCORDION) study, during which participants were treated according to their health care provider's judgment. Cardiovascular and other health-related outcomes were prospectively collected and analyzed using an intention-to-treat approach according to the group to which participants were originally allocated. RESULTS: A total of 8,601 people, representing 98% of those who did not suffer a primary outcome or death during the ACCORD trial, were monitored for a median of 8.8 years and a mean of 7.7 years from randomization. Intensive glucose lowering for a mean of 3.7 years had a neutral long-term effect on the primary composite outcome (nonfatal myocardial infarction, nonfatal stroke, or cardiovascular death), death from any cause, and an expanded composite outcome that included all-cause death. Moreover, the risk of cardiovascular mortality noted during the active phase (hazard ratio 1.49; 95% CI 1.19, 1.87; P < 0.0001) decreased (HR 1.20; 95% CI 1.03, 1.39; P = 0.02). CONCLUSIONS: In high-risk people with type 2 diabetes monitored for 9 years, a mean of 3.7 years of intensive glycemic control had a neutral effect on death and nonfatal cardiovascular events but increased cardiovascular-related death.

Original languageEnglish (US)
Pages (from-to)701-708
Number of pages8
JournalDiabetes care
Issue number5
StatePublished - May 2016

Bibliographical note

Publisher Copyright:
© 2016 by the American Diabetes Association.


Dive into the research topics of 'Nine-year effects of 3.7 years of intensive glycemic control on cardiovascular outcomes'. Together they form a unique fingerprint.

Cite this